-
1
-
-
0032510309
-
Treatment of postmenopausal osteoporosis
-
Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med 1998, 338:736-746.
-
(1998)
N Engl J Med
, vol.338
, pp. 736-746
-
-
Eastell, R.1
-
2
-
-
22044443714
-
Clinical practice. Screening for osteoporosis
-
Raisz L.G. Clinical practice. Screening for osteoporosis. N Engl J Med 2005, 353:164-171.
-
(2005)
N Engl J Med
, vol.353
, pp. 164-171
-
-
Raisz, L.G.1
-
3
-
-
0034719619
-
Osteoporosis prevention, diagnosis, and therapy
-
[cited 2013, May 28, Available at ]M 27_#2013;29
-
Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement March 27-29 2000, 17:1-36. [cited 2013, May 28, Available at http://consensus.nih.gov/2000/2000Osteoporosis111html.htm].
-
(2000)
NIH Consens Statement
, vol.17
, pp. 1-36
-
-
-
4
-
-
33744992495
-
Osteoporosis
-
Sambrook P., Cooper C. Osteoporosis. Lancet 2006, 367:2010-2018.
-
(2006)
Lancet
, vol.367
, pp. 2010-2018
-
-
Sambrook, P.1
Cooper, C.2
-
5
-
-
21344464904
-
Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women
-
Recker R.R., Gallagher R., MacCosbe P.E. Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 2005, 80:856-861.
-
(2005)
Mayo Clin Proc
, vol.80
, pp. 856-861
-
-
Recker, R.R.1
Gallagher, R.2
MacCosbe, P.E.3
-
6
-
-
33746821808
-
Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases
-
Siris E.S., Harris S.T., Rosen C.J., Barr C.E., Arvesen J.N., Abbott T.A., et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 2006, 81:1013-1022.
-
(2006)
Mayo Clin Proc
, vol.81
, pp. 1013-1022
-
-
Siris, E.S.1
Harris, S.T.2
Rosen, C.J.3
Barr, C.E.4
Arvesen, J.N.5
Abbott, T.A.6
-
7
-
-
0037673945
-
Osteoclast differentiation and activation
-
Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
-
(2003)
Nature
, vol.423
, pp. 337-342
-
-
Boyle, W.J.1
Simonet, W.S.2
Lacey, D.L.3
-
8
-
-
69049083492
-
Denosumab for prevention of fractures in postmenopausal women with osteoporosis
-
Cummings S.R., San Martin J., McClung M.R., Siris E.S., Eastell R., Reid I.R., et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009, 361:756-765.
-
(2009)
N Engl J Med
, vol.361
, pp. 756-765
-
-
Cummings, S.R.1
San Martin, J.2
McClung, M.R.3
Siris, E.S.4
Eastell, R.5
Reid, I.R.6
-
9
-
-
58149099647
-
Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial
-
Brown J.P., Prince R.L., Deal C., Recker R.R., Kiel D.P., de Gregorio L.H., et al. Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res 2009, 24:153-161.
-
(2009)
J Bone Miner Res
, vol.24
, pp. 153-161
-
-
Brown, J.P.1
Prince, R.L.2
Deal, C.3
Recker, R.R.4
Kiel, D.P.5
de Gregorio, L.H.6
-
10
-
-
77953454405
-
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
-
Kendler D.L., Roux C., Benhamou C.L., Brown J.P., Lillestol M., Siddhanti S., et al. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy. J Bone Miner Res 2010, 25:72-81.
-
(2010)
J Bone Miner Res
, vol.25
, pp. 72-81
-
-
Kendler, D.L.1
Roux, C.2
Benhamou, C.L.3
Brown, J.P.4
Lillestol, M.5
Siddhanti, S.6
-
11
-
-
84886773001
-
Psychometric properties of the Osteoporosis-Specific Morisky Medication Adherence Scale (OS-MMAS) in postmenopausal women with osteoporosis (OP) treated with bisphosphonates (BP)
-
Reynolds K., Viswanathan H., O'Malley C., Muntner P., Harrison T., Cheetham T.C., et al. Psychometric properties of the Osteoporosis-Specific Morisky Medication Adherence Scale (OS-MMAS) in postmenopausal women with osteoporosis (OP) treated with bisphosphonates (BP). J Bone Miner Res 2011, 24:S367.
-
(2011)
J Bone Miner Res
, vol.24
-
-
Reynolds, K.1
Viswanathan, H.2
O'Malley, C.3
Muntner, P.4
Harrison, T.5
Cheetham, T.C.6
-
12
-
-
0022072706
-
Testing for qualitative interactions between treatment effects and patient subsets
-
Gail M., Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985, 41:361-372.
-
(1985)
Biometrics
, vol.41
, pp. 361-372
-
-
Gail, M.1
Simon, R.2
-
13
-
-
78349249359
-
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research
-
Shane E., Burr D., Ebeling P.R., Abrahamsen B., Adler R.A., Brown T.D., et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2010, 25:2267-2294.
-
(2010)
J Bone Miner Res
, vol.25
, pp. 2267-2294
-
-
Shane, E.1
Burr, D.2
Ebeling, P.R.3
Abrahamsen, B.4
Adler, R.A.5
Brown, T.D.6
-
14
-
-
79951746928
-
Effects of denosumab on bone turnover markers in postmenopausal osteoporosis
-
Eastell R., Christiansen C., Grauer A., Kutilek S., Libanati C., McClung M.R., et al. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. J Bone Miner Res 2011, 26:530-537.
-
(2011)
J Bone Miner Res
, vol.26
, pp. 530-537
-
-
Eastell, R.1
Christiansen, C.2
Grauer, A.3
Kutilek, S.4
Libanati, C.5
McClung, M.R.6
-
15
-
-
33344469853
-
Denosumab in postmenopausal women with low bone mineral density
-
McClung M.R., Lewiecki E.M., Cohen S.B., Bolognese M.A., Woodson G.C., Moffett A.H., et al. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 2006, 354:821-831.
-
(2006)
N Engl J Med
, vol.354
, pp. 821-831
-
-
McClung, M.R.1
Lewiecki, E.M.2
Cohen, S.B.3
Bolognese, M.A.4
Woodson, G.C.5
Moffett, A.H.6
-
16
-
-
79951689707
-
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: six-year results of a phase 2 clinical trial
-
Miller P.D., Wagman R.B., Peacock M., Lewiecki E.M., Bolognese M.A., Weinstein R.L., et al. Effect of denosumab on bone mineral density and biochemical markers of bone turnover: six-year results of a phase 2 clinical trial. J Clin Endocrinol Metab 2011, 96:394-402.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 394-402
-
-
Miller, P.D.1
Wagman, R.B.2
Peacock, M.3
Lewiecki, E.M.4
Bolognese, M.A.5
Weinstein, R.L.6
-
17
-
-
34250165747
-
Intravenous zoledronic acid 5mg in the treatment of postmenopausal women with low bone density previously treated with alendronate
-
McClung M., Recker R., Miller P., Fiske D., Minkoff J., Kriegman A., et al. Intravenous zoledronic acid 5mg in the treatment of postmenopausal women with low bone density previously treated with alendronate. Bone 2007, 41:122-128.
-
(2007)
Bone
, vol.41
, pp. 122-128
-
-
McClung, M.1
Recker, R.2
Miller, P.3
Fiske, D.4
Minkoff, J.5
Kriegman, A.6
-
18
-
-
84879122105
-
Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial
-
Recknor C., Czerwinski E., Bone H.G., Bonnick S.L., Binkley N., Palacios S., et al. Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial. Obstet Gynecol 2013, 121:1291-1299.
-
(2013)
Obstet Gynecol
, vol.121
, pp. 1291-1299
-
-
Recknor, C.1
Czerwinski, E.2
Bone, H.G.3
Bonnick, S.L.4
Binkley, N.5
Palacios, S.6
-
19
-
-
84863116878
-
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures
-
Austin M., Yang Y.C., Vittinghoff E., Adami S., Boonen S., Bauer D.C., et al. Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures. J Bone Miner Res 2012, 27:687-693.
-
(2012)
J Bone Miner Res
, vol.27
, pp. 687-693
-
-
Austin, M.1
Yang, Y.C.2
Vittinghoff, E.3
Adami, S.4
Boonen, S.5
Bauer, D.C.6
|